Hyperparathyroidism in chronic kidney disease: complexities within the commonplace

Author： Cai Michael M   McMahon Lawrence P   Smith Edward R   Williams David S   Holt Stephen G  

Publisher： Royal College Of Physicians

ISSN： 1470-2118

Source： Clinical Medicine, Vol.12, Iss.4, 2012-08, pp. : 333-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paricalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease

By Cheng Steven   Coyne Daniel  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 617-621

Informa Healthcare

Access to resources Recommend Favorite

Management of Secondary Hyperparathyroidism in the Elderly Patient with Chronic Kidney Disease

By Cozzolino Mario   Gallieni Maurizio   Pasho Sabina   Fallabrino Giuditta   Ciceri Paola   >   Olivi Laura   Brancaccio Diego  

Drugs & Aging, Vol. 26, Iss. 6, 2009-06 ,pp. : 457-468

Adis International

Access to resources Recommend Favorite

Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis

By  

Hemodialysis International, Vol. 20, Iss. 4, 2016-10 ,pp. : 589-600

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost Effectiveness of Paricalcitol versus a Non-Selective Vitamin D Receptor Activator for Secondary Hyperparathyroidism in the UK: A Chronic Kidney Disease Markov Model

By Nuijten Mark  

Clinical Drug Investigation, Vol. 30, Iss. 8, 2010-08 ,pp. : 545-557

Adis International

Access to resources Recommend Favorite

Clinical management of chronic kidney disease

By Methven Shona   MacGregor Mark S  

Clinical Medicine, Vol. 9, Iss. 3, 2009-06 ,pp. : 269-272

Royal College Of Physicians

Access to resources Recommend Favorite